Application 209025

Type
ANDA
Sponsor
ARISE

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDETABLET;ORAL5MGNoNo
002OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDETABLET;ORAL2.5MGNoYes

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
64980-431OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDERising Pharmaceuticals, Inc.ANDACurrent
68071-4395OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDENuCare Pharmaceuticals,Inc.ANDACurrent
68788-7234OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEPreferred Pharmaceuticals, Inc.ANDACurrent
68788-7234OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEPreferred Pharmaceuticals, Inc.ANDACurrent
68788-7234OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEPreferred Pharmaceuticals, Inc.ANDACurrent
70518-1294OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEREMEDYREPACK INC.ANDACurrent
70518-1294OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEREMEDYREPACK INC.ANDACurrent
71335-1014OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEBryant Ranch PrepackANDACurrent
71335-1014OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDEBryant Ranch PrepackANDACurrent